drugset / Trial / NCT05257148

Effectiveness and Safety of Combination of Nebivolol and Zofenopril in Hypertensive patIents Versus Each Monotherapy

NCT05257148

Phase 4 Completed 283 enrolled Menarini International Operations Luxembourg SA
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Open-label, interventional clinical trial to assess effectiveness and safety of the extemporaneous combination of nebivolol and zofenopril calcium in grade 1 to 2 hypertensive patients versus each monotherapy

Timeline

Start
2021-05-26
Primary completion
2021-12-22
Completion
2021-12-22

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nebivolol Other / unclassified 5 mg Oral
Comparator Zofenopril Small molecule 30 mg Oral

Indications